IPG Clause Samples
The IPG (Interim Payment Guarantee) clause establishes the requirement for a party to provide a financial guarantee ensuring payment obligations are met during the course of a contract. Typically, this clause applies in transactions where goods or services are delivered in stages, and the guarantee serves as security for interim payments before final settlement. By requiring an IPG, the clause protects the receiving party from the risk of non-payment during the contract term, thereby facilitating trust and smooth progress in ongoing business arrangements.
IPG has asserted counterclaims against JDSU and SDL in the Arbitration and the State Court Action sounding in breach of contract, unfair competition and violation of federal and state laws governing anti-trust and unfair competition;
IPG on behalf of itself and its direct and indirect subsidiaries, and other Affiliates, and their respective directors, officers, employees, agents and representatives, including, without limitation, its and their attorneys, and their respective predecessors, successors, assigns, heirs and legal representatives, hereby releases, acquits, and forever absolutely discharges JDSU, its direct and indirect subsidiaries, and other Affiliates, and their respective directors, officers, employees, agents and representatives, including, without limitation, its and their attorneys, and their respective predecessors (including SDL), successors, assigns, heirs and legal representatives, of and from any and all actions, causes of action, claims, demands, damages, theories, affirmative defenses, judgments, liens, indebtedness, losses, expenses (including, without limitation, attorneys' fees and disbursements) and liabilities of every kind and character, whether known or unknown, suspected or unsuspected, certain or speculative, existing or prospective, liquidated or unliquidated, whether under the laws of the United States or any state thereof or any other country, which exist as of the date of this Settlement or may have come into existence at any time prior to the date of this Settlement.
IPG. Address: ▇▇ ▇▇▇ ▇▇▇▇▇▇▇ ▇▇▇▇, Oxford, Massachusetts, USA Fax: +▇-▇▇▇-▇▇▇-▇▇▇▇ For the attention of: General Counsel
IPG. Laser GmbH, a legal entity organized and existing under the laws of Germany with the registration number HR B 4466 and having its registered address at ▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇, ▇-▇▇▇▇▇ ▇▇▇▇▇▇▇, Germany (“IPG”);
IPG. Provide contact information for Company employees who will need access to the User Interface:
IPG. Address: ▇▇▇▇▇▇▇▇▇▇▇▇▇▇ ▇, ▇-▇▇▇▇▇ ▇▇▇▇▇▇▇, ▇▇▇▇▇▇▇ Fax: ▇▇.▇▇▇▇.▇▇▇▇.▇▇▇ For the attention of: General Director
IPG. Polymer and IFCO Manufacturing each has the requisite corporate power and authority to enter into this Agreement and consummate the transactions contemplated hereby. The execution, delivery and performance of this Agreement have been approved by all requisite corporate action of IPG, Polymer and IFCO Manufacturing. This Agreement has been duly and validly executed and delivered by IPG, Polymer and IFCO Manufacturing, and, assuming the due authorization, execution and delivery hereof by the IFCO Group, constitutes a valid and binding agreement of IPG, Polymer and IFCO Manufacturing, enforceable against each in accordance with its terms, except as that enforceability may be subject to: (i) any applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws affecting or relating to enforcement of creditors' rights generally; and (ii) general principles of equity.
IPG. The QIO shall issue an invitation to the hospital Chief Executive Officer (CEO) requesting participation in the IPGs. To solicit hospital participation, the QIO may use the standard letter that CMS will supply to the QIO, alter this standard CMS letter, or use a letter developed by the QIO. The CEO of any hospital interested in participating in any of the IPGs will need to sign and submit the completed CMS form letter, an alternate form letter provided by the QIO, or submit a signed letter of interest in order for his/her facility to be considered for inclusion in one or more of the IPGs. If the CEO is unavailable to sign the letter, his or her designated representative may sign for the hospital. The QIO shall select identified participants that reflect a broad distribution within the state/jurisdiction with regard to the following characteristics: size of provider, geographic distribution, performance at baseline, and need for QIO assistance. The Project Officer and Task 1c GTLs must review and approve the QIO’s IPGs based on these criteria. Data from all hospitals initially selected for inclusion in the IPGs will be used for evaluation purposes. Each IPG for Task 1c1 must consist of 15% of the PPS hospitals in the state/jurisdiction, with no fewer than 6 and no more than 36 hospitals. ▇▇▇▇▇▇▇ states may request approval from the PO and GTLs to include less than 6 hospitals in the IPG. NOTE: the SCIP and SIOC IPGs may include CAHs as described below. For the SCIP IPG, the 15% pertains to the PPS hospitals meeting the 300 major surgical procedures criterion. For the SIOC IPGs, the 15% includes both PPS and reporting CAHs. Public Health Service and tribally owned hospitals are eligible to become identified participants if they meet the criteria stated below. All identified participant hospitals in Tasks 1c1 (excluding CAHs participating in the SCIP IPG) must submit performance data on the 10-measure set as required under Section 501(b) of MMA indicated in Table 1. The IPGs can overlap to any degree. Extra credit is available for doing additional work in either the ACM or SCIP IPGs, but not both IPGs. QIOs may elect to participate in extra credit for both IPGs. The successful completion of the extra credit will only be counted one time for this task. In order to receive the extra credit a QIO must meet the requirements as specified below under each IPG description. Partial credit will not be given if a QIO falls short of the full requirement for extra credit...
IPG and SDL agree that this Agreement is considered Confidential Information and subject to the provisions of this Article 16. Neither party shall without the prior written consent of the other party, publicize the fact or contents of this Agreement, except as the company is required to be disclosed under applicable law, or as the company discloses to it's accountants, lawyers, commercial and investment bankers or other advisors, notwithstanding anything herein to the contrary. In the event that SDL or IPG is required to release information related to this Agreement (other than to the party's accountants, lawyers, commercial and investment bankers or other advisors), timely consent notice to the other party shall be provided by IPG for prior to such release of information to the extent possible.
IPG and SDL agree that this Agreement is considered Confidential Information and subject to the provisions of this Article 16. Neither party shall without the prior written consent of the other party, publicize the fact or contents of this Agreement. In the event that SDL is required to release information related to this Agreement, timely consent shall be provided by IPG for such release of information.